Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 22% ± 10% | |
lung | 12 studies | 31% ± 9% | |
kidney | 7 studies | 26% ± 8% | |
intestine | 7 studies | 30% ± 13% | |
brain | 7 studies | 25% ± 8% | |
eye | 6 studies | 23% ± 8% | |
liver | 6 studies | 29% ± 20% | |
bone marrow | 5 studies | 20% ± 4% | |
uterus | 5 studies | 31% ± 14% | |
pancreas | 4 studies | 41% ± 16% | |
lymph node | 4 studies | 29% ± 12% | |
breast | 4 studies | 28% ± 4% | |
placenta | 3 studies | 23% ± 8% | |
esophagus | 3 studies | 35% ± 22% | |
skin | 3 studies | 22% ± 4% | |
thymus | 3 studies | 48% ± 23% | |
prostate | 3 studies | 37% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8165.49 | 1445 / 1445 | 100% | 122.56 | 183 / 183 |
lung | 100% | 8334.09 | 578 / 578 | 100% | 113.38 | 1155 / 1155 |
stomach | 100% | 6990.19 | 359 / 359 | 100% | 125.20 | 286 / 286 |
breast | 100% | 9720.11 | 459 / 459 | 100% | 132.85 | 1117 / 1118 |
prostate | 100% | 6731.13 | 245 / 245 | 100% | 123.89 | 501 / 502 |
brain | 100% | 7021.60 | 2636 / 2642 | 100% | 104.60 | 705 / 705 |
ovary | 100% | 10093.79 | 180 / 180 | 100% | 82.81 | 429 / 430 |
bladder | 100% | 8447.62 | 21 / 21 | 99% | 124.11 | 501 / 504 |
skin | 100% | 10983.04 | 1809 / 1809 | 99% | 109.17 | 469 / 472 |
intestine | 100% | 8721.23 | 966 / 966 | 99% | 139.06 | 523 / 527 |
pancreas | 100% | 5242.32 | 327 / 328 | 99% | 78.81 | 177 / 178 |
thymus | 100% | 6731.67 | 653 / 653 | 99% | 82.70 | 599 / 605 |
uterus | 100% | 8734.66 | 170 / 170 | 99% | 129.41 | 454 / 459 |
kidney | 100% | 7716.03 | 89 / 89 | 97% | 78.63 | 874 / 901 |
liver | 99% | 4723.38 | 224 / 226 | 97% | 63.71 | 395 / 406 |
adrenal gland | 100% | 8192.69 | 258 / 258 | 96% | 80.75 | 221 / 230 |
adipose | 100% | 10450.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8708.57 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 132.84 | 29 / 29 |
muscle | 100% | 9360.55 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7188.82 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 128.24 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.31 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 85.00 | 79 / 80 |
heart | 96% | 6491.29 | 826 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 7286.75 | 878 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007339 | Biological process | binding of sperm to zona pellucida |
GO_1904871 | Biological process | positive regulation of protein localization to Cajal body |
GO_0061077 | Biological process | chaperone-mediated protein folding |
GO_1904874 | Biological process | positive regulation of telomerase RNA localization to Cajal body |
GO_0007021 | Biological process | tubulin complex assembly |
GO_1904851 | Biological process | positive regulation of establishment of protein localization to telomere |
GO_0006457 | Biological process | protein folding |
GO_0050821 | Biological process | protein stabilization |
GO_0090666 | Biological process | scaRNA localization to Cajal body |
GO_0051973 | Biological process | positive regulation of telomerase activity |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0001669 | Cellular component | acrosomal vesicle |
GO_0005874 | Cellular component | microtubule |
GO_0005832 | Cellular component | chaperonin-containing T-complex |
GO_0002199 | Cellular component | zona pellucida receptor complex |
GO_0000792 | Cellular component | heterochromatin |
GO_0005813 | Cellular component | centrosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005829 | Cellular component | cytosol |
GO_0044297 | Cellular component | cell body |
GO_0000242 | Cellular component | pericentriolar material |
GO_0044183 | Molecular function | protein folding chaperone |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0140662 | Molecular function | ATP-dependent protein folding chaperone |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | TCP1 |
Protein name | T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) T-complex 1 T-complex protein 1 subunit alpha (CCT-alpha) |
Synonyms | CCTA CCT1 |
Description | FUNCTION: Component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex that assists the folding of proteins upon ATP hydrolysis . The TRiC complex mediates the folding of WRAP53/TCAB1, thereby regulating telomere maintenance . As part of the TRiC complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia . The TRiC complex plays a role in the folding of actin and tubulin (Probable). . |
Accessions | ENST00000543517.5 ENST00000537390.5 ENST00000539756.1 F5H676 ENST00000536394.1 F5H136 ENST00000392168.6 ENST00000544255.5 ENST00000538128.5 ENST00000420894.6 E7ERF2 E7EQR6 F5H7Y1 ENST00000539948.5 F5H726 F5GYL4 F5GZI8 P17987 F5GZ03 ENST00000538530.5 ENST00000321394.12 F5H282 |